CTOs on the Move

Icebrkr

www.icebr.kr

 
The online dating industry has been growing at a rapid rate over the past decade with no signs of slowing down (over 50 million online daters in the US alone). The vast majority of those users (18-34) perceive the biggest apps as either hard to take seriously (Tinder) or too old to use (Match, eHarmony). On top of that, there are professional dating coaches that cost upwards of $4,000/month (seriously) just to help people navigate these apps. Icebrkr is a dating app aimed at combining the best parts of these tools while removing the negatives.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Forio Online Simulations

Forio Online Simulations is a San Francisco, CA-based company in the Software and Internet sector.

Coreopsys Software Labs

Coreopsys Software Labs is a Atlanta, GA-based company in the Software and Internet sector.

RandB Software Development

R&B Software Development is a Portland, OR-based company in the Software and Internet sector.

Prevalent Software

Prevalent Software is a Colorado Springs, CO-based company in the Software and Internet sector.

Cypher Genomics

Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.